98%
921
2 minutes
20
Background: A current limitation to the use of lung PET/CT is the absence of a tool that reliably and reproducibly quantifies the intensity of tracer uptake. We aim to develop a quantitative approach for lung perfusion PET/CT imaging. Sixty patients who underwent [68Ga]Ga-MAA PET/CT scans before (M0) and 3 months (M3) after completion of radiotherapy were analyzed. The anatomical lung volume (ALV) was delineated on the CT scan. CT and PET images were co-registered, and the ALV was transferred onto the PET images. The measured activity concentration (kBq/L) in each voxel was converted in three metrics: SUV based on normalizing the measured activity to the patient's weight (kg) and the injected dose (kBq); SUVp by normalizing to the ALV (L) and the injected dose (kBq); pulmonary uptake value (PUV) by normalizing to the ALV (L) and the total activity measured in the ALV (kBq). The mean SUV, SUVp and PUV values within the ALV were measured.
Results: The mean (SD) SUV in the ALV was 9.90 (5.24) with an inconsistently wide range of values from 0.11 to 22.52. The correlation coefficient between the patient's weight and the ALV was 0.14. The mean (SD) SUVp in the ALV was 0.54 (0.09). The mean (SD) percentage of [68Ga]Ga-MAA lung retention was 58.2% (7.7%), with significant variability both between patients and within repeated scans of the same patient. The mean PUV in the ALV used for normalization was equal to 1. Quantitative methods were tested in challenging scenarios for quantification, including patients exhibiting decorrelation between ALV and patient's weight and patients with different percentage of [68Ga]Ga-MAA lung retention between M0 and M3. In contrast to the SUV and SUVp metrics, the PUV method showed coherent results compared to visual analysis.
Conclusion: The patient's weight and the injected activity are not suitable parameters for normalization in lung perfusion quantification. We proposed a quantitative metric for lung perfusion PET/CT imaging, based on normalizing the measured activity to the ALV computed from a co-registered CT scan and to the total activity measured in the ALV.
Trial Registration: NCT04942275. Registered 19 June 2021.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12214062 | PMC |
http://dx.doi.org/10.1186/s13550-025-01274-y | DOI Listing |
JMIR Public Health Surveill
September 2025
Earth Observation Centre (EOC), Institute of Climate Change, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia.
Background: Neighborhoods resulting from rapid urbanization processes are often saturated with eateries for local communities, potentially increasing exposure to unhealthy foods and creating diabetogenic residential habitats.
Objective: We examined the association between proximity of commercial food outlets to local neighborhood residences and type 2 diabetes (T2D) cases to explore how local T2D rates vary by location and provide policy-driven metrics to monitor food outlet density as a potential control for high local T2D rates.
Methods: This cross-sectional ecological study included 11,354 patients with active T2D aged ≥20 years geocoded using approximate neighborhood residence aggregated to area-level rates and counts by subdistricts (mukims) in Penang, northern Malaysia.
Neurology
October 2025
Department of Neurology, Mayo Clinic, Rochester, MN.
Monoclonal gammopathy-associated myopathies (MGAMs) are rare yet treatable myopathies that occur in association with monoclonal gammopathies. These myopathies include light chain (AL) amyloidosis myopathy, sporadic late-onset nemaline myopathy (SLONM), scleromyxedema with associated myopathy, and newly reported monoclonal gammopathy-associated glycogen storage myopathy (MGGSM), including the vacuolar myopathy with monoclonal gammopathy and stiffness. All these 4 distinct subtypes of MGAMs typically present in patients aged 40 or older, frequently with a subacute onset of rapidly progressive proximal and axial muscle weakness.
View Article and Find Full Text PDFJCO Clin Cancer Inform
August 2025
Telperian, Austin, TX.
Purpose: Lymphocytes play critical roles in cancer immunity and tumor surveillance. Radiation-induced lymphopenia (RIL) is a common side effect observed in patients with cancer undergoing chemoradiation therapy (CRT), leading to impaired immunity and worse clinical outcomes. Although proton beam therapy (PBT) has been suggested to reduce RIL risk compared with intensity-modulated radiation therapy (IMRT), this study used Bayesian counterfactual machine learning to identify distinct patient profiles and inform personalized radiation modality choice.
View Article and Find Full Text PDFCrit Care Med
July 2025
Division of Critical Care, Department of Medicine, The Queen's Medical Center, Honolulu, HI.
Objectives: To evaluate the relationship between the duration of pre-extracorporeal membrane oxygenation (ECMO) mechanical ventilation and mortality in acute respiratory distress syndrome (ARDS) patients undergoing venovenous ECMO.
Design: Retrospective cross-sectional study using the National Inpatient Sample database.
Setting: National Inpatient Sample database from January 2019 to December 2022.
Am J Physiol Cell Physiol
September 2025
Institute of Pharmacology and Toxicology, Goethe University Frankfurt, Frankfurt, Germany.
The A20 binding inhibitor of nuclear factor-kappa B (NF-κB)-1 (ABIN-1) serves as a ubiquitin sensor and autophagy receptor, crucial for modulating inflammation and cell death. Our previous in vitro investigation identified the LC3-interacting region (LIR) motifs 1 and 2 of ABIN-1 as key mitophagy regulators. This study aimed to explore the in vivo biological significance of ABIN1-LIR domains using a novel CRISPR-engineered ABIN1-ΔLIR1/2 mouse model, which lacks both LIR motifs.
View Article and Find Full Text PDF